Endocrine Society of Australia Annual Scientific Meeting

Kate Endocrine Society of Australia 2018 scaled 1In August I travelled to Adelaide for the Endocrine Society of Australia Annual Scientific Meeting.

This was a three day conference, with endocrinologists and scientists involved in the care of people with endocrine disorders of all sorts – so a very varied program.

During the conference I had the opportunity to speak with many specialists who care for NETs patients, particularly pheochromocytomas and paragangliomas (many who had never heard of the Unicorn Foundation or our services, so this was great). I also spoke with several diabetes educators, who were very interested to discuss the care of people who have had surgically induced diabetes, and also the impact of somatostatin analogues on blood sugar regulation. Many took copies of our information booklets and signed up to our Health Professional Network, to receive regular updates from us as well.

Whilst in Adelaide it was also a great opportunity to catch up with Kathy, our wonderful SA Support Group facilitator, and the team at Queen Elizabeth Hospital (where many of our South Australian patients attend for treatment).

It is always great to have the opportunity to travel and connect with health professionals who care for people who have experienced NETs!

This activity was jointly funded by the Australian Government Department of Health and donations from our Unicorn Foundation community.

Dept of Health logo

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

Raising Awareness for NETs on World Cancer Day in WA

Australia delivers excellent cancer care, but not equally

AUS-NET Update, January 2026

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.